{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:23Z","timestamp":1791924203345,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004413","name":"T\u00fcrk Nefroloji Dernegi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004413","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ekir.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T12:29:39Z","timestamp":1641817779000},"page":"752-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Kidney Transplant Outcomes of Patients With Multiple Myeloma"],"prefix":"10.1016","volume":"7","author":[{"given":"Cihan","family":"Heybeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8495-9782","authenticated-orcid":false,"given":"Andrew J.","family":"Bentall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9072-9871","authenticated-orcid":false,"given":"Mariam Priya","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-0506","authenticated-orcid":false,"given":"Hatem","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K.","family":"Buadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-9512","authenticated-orcid":false,"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Schinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.01.003_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djy167","article-title":"Acute kidney injury in patients receiving systemic treatment for cancer: a population-based cohort study","volume":"111","author":"Kitchlu","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ekir.2022.01.003_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/ejh.12164","volume":"91","author":"Terpos","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ekir.2022.01.003_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group","volume":"65","author":"Knudsen","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ekir.2022.01.003_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/bjh.12818","article-title":"Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma","volume":"165","author":"Murphy","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2022.01.003_bib5","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1038\/bcj.2015.20","article-title":"Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma","volume":"5","author":"Gonsalves","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.ekir.2022.01.003_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","article-title":"Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients","volume":"270","author":"Port","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2022.01.003_bib7","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.V9112135","article-title":"Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up","volume":"9","author":"Schnuelle","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.01.003_bib8","first-page":"1577","article-title":"Renal transplantation in multiple myeloma. Case report and review of the literature [published correction appears in Transplantation. 1997;63:916]","volume":"62","author":"Dagher","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.01.003_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1053\/j.ajkd.2016.12.023","article-title":"Kidney transplantation for kidney failure due to multiple myeloma: case reports","volume":"69","author":"Le","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.01.003_bib10","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1097\/TXD.0000000000000716","article-title":"Kidney transplantation in patients with active multiple myeloma: case reports","volume":"3","author":"Lum","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.ekir.2022.01.003_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ckj\/sfy137","article-title":"Risk of relapse of multiple myeloma following kidney transplantation","volume":"12","author":"Shah","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2022.01.003_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ckj\/sfz128","article-title":"Kidney transplantation for active multiple myeloma or smoldering myeloma: a case\u2013control study","volume":"14","author":"Kormann","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2022.01.003_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.mayocp.2017.01.003","article-title":"Therapy for relapsed multiple myeloma: guidelines from the Mayo stratification for myeloma and risk-adapted therapy","volume":"92","author":"Dingli","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2022.01.003_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/annonc\/mdt483","article-title":"Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents","volume":"25","author":"Dimopoulos","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ekir.2022.01.003_bib15","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.3324\/haematol.2017.183475","article-title":"Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study","volume":"103","author":"Thorsteinsdottir","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.ekir.2022.01.003_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3324\/haematol.2017.178103","article-title":"Outcome and survival of myeloma patients diagnosed 2008\u20132015. Real-world data on 4904 patients from the Swedish Myeloma Registry","volume":"103","author":"Blimark","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.ekir.2022.01.003_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1681\/ASN.2014090876","article-title":"ESRD due to multiple myeloma in the United States, 2001\u20132010","volume":"27","author":"Reule","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.01.003_bib18","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ekir.2022.01.003_bib19","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ekir.2022.01.003_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.01.003_bib21","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ekir.2021.03.002","article-title":"Evidence for transition from light chain deposition disease by immunofluorescence-only to classic light chain deposition disease","volume":"6","author":"Nasr","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2022.01.003_bib22","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2016-04-711903","article-title":"T\u00a0cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma","volume":"128","author":"Ali","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2022.01.003_bib23","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1172\/JCI126397","article-title":"B\u00a0cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma","volume":"129","author":"Cohen","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2022.01.003_bib24","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.01.003_bib25","doi-asserted-by":"crossref","first-page":"c228","DOI":"10.1159\/000341760","article-title":"Defining the role of renal transplantation in the modern management of multiple myeloma and other plasma cell dyscrasias","volume":"120","author":"Bansal","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ekir.2022.01.003_bib26","article-title":"Safety and efficacy of high dose melphalan and autologous stem cell transplantation prior to renal allograft in end-stage renal failure secondary to monoclonal immunoglobulin deposition disease","volume":"3","author":"Bansal","year":"2011","journal-title":"Cell Ther Transplant"},{"key":"10.1016\/j.ekir.2022.01.003_bib27","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1111\/j.1399-0012.2009.01155.x","article-title":"Solid organ transplantation in survivors of hematopoietic cell transplantation: a single institution case series and literature review","volume":"24","author":"Beitinjaneh","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ekir.2022.01.003_bib28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00007890-200211270-00011","article-title":"Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease","volume":"74","author":"B\u00fchler","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.01.003_bib29","doi-asserted-by":"crossref","unstructured":"Chitty DW, Hartley-Brown MA, Abate M, et\u00a0al. Kidney transplantation in patients with multiple myeloma: narrative analysis and review of the last 2 decades. Nephrol Dial Transplant. Published online December 9, 2020. https:\/\/doi.org\/10.1093\/ndt\/gfaa361","DOI":"10.1093\/ndt\/gfaa361"},{"key":"10.1016\/j.ekir.2022.01.003_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.transproceed.2018.10.005","article-title":"Kidney transplantation after hematopoietic cell transplantation in plasma cell dyscrasias: case reports","volume":"51","author":"Dom\u00ednguez-Pimentel","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2022.01.003_bib31","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1600-6143.2006.01434.x","article-title":"Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in\u00a0vivo and in\u00a0vitro analyses","volume":"6","author":"Fudaba","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.01.003_bib32","first-page":"124","article-title":"Outcomes of renal transplantation in patients with previous hematologic malignancies","volume":"3","author":"Hedvat","year":"2019","journal-title":"J\u00a0Onco-Nephrol"},{"key":"10.1016\/j.ekir.2022.01.003_bib33","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1097\/TP.0000000000002449","article-title":"Kidney transplant in the era of modern therapy for multiple myeloma","volume":"102","author":"Huskey","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.01.003_bib34","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1093\/ndt\/gfl403","article-title":"A\u00a0case of successful double sequential bone marrow and kidney transplantations in a patient with multiple myeloma","volume":"21","author":"Khoriaty","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2022.01.003_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.01.003_bib36","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/ndt\/gfm918","article-title":"Long-term outcome of autologous stem cell transplantation in light chain deposition disease","volume":"23","author":"Lorenz","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2022.01.003_bib37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1523-1755.2004.00427.x","article-title":"High dose chemotherapy in light chain or light and heavy chain deposition disease","volume":"65","author":"Royer","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.01.003_bib38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/nep.12116","article-title":"Renal transplant in plasma cell dyscrasias with lenalidomide treatment after autologous stem cell transplantation","volume":"18","author":"S\u00e1nchez Quintana","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2022.01.003_bib39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e31820a3068","article-title":"Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease","volume":"91","author":"Spitzer","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.01.003_bib40","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.transproceed.2013.10.005","article-title":"Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report","volume":"45","author":"Wagner","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2022.01.003_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41408-018-0065-8","article-title":"Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies","volume":"8","author":"Ravi","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.ekir.2022.01.003_bib42","doi-asserted-by":"crossref","first-page":"6471901","DOI":"10.1155\/2016\/6471901","article-title":"Combined bone marrow and kidney transplantation for the induction of specific tolerance","volume":"2016","author":"Chen","year":"2016","journal-title":"Adv Hematol"},{"key":"10.1016\/j.ekir.2022.01.003_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ajt.14970","article-title":"Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor\u2014a multicenter analysis","volume":"19","author":"Eder","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.01.003_bib44","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00007890-200106150-00031","article-title":"Tolerance in renal transplantation after allogeneic bone marrow transplantation\u20146-year follow-up","volume":"71","author":"Sellers","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.01.003_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ckj\/sfz003","article-title":"Multiple myeloma and kidney transplantation: the beginning of a new era","volume":"12","author":"Van den Bosch","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2022.01.003_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4065\/mcp.2009.0677","article-title":"Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie","volume":"85","author":"Kapoor","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2022.01.003_bib47","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1365-2141.2001.02530.x","article-title":"The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma","volume":"112","author":"Davies","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:39:25Z","timestamp":1762832365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024922000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2468024922000031"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.01.003","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Transplant Outcomes of Patients With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}